Form 4: Director Michael F. Angelo Receives VirnetX Equity Grant
Statement of Changes in Beneficial Ownership
Director Michael F. Angelo was granted 7,500 shares of restricted common stock in VirnetX Holding Corp.
Summary
- Director Michael F. Angelo acquired 7,500 shares of restricted common stock on June 11, 2026.
- The shares were granted at a price of $0 per share as part of an equity incentive plan.
- Following this transaction, the director's total beneficial ownership of common stock is 29,209 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of immediate market impact.
Positives
- Alignment of director interests with shareholders through equity-based compensation.
Negatives
- None noted.
Risks
- Vesting is contingent upon the director maintaining continuous status as a Service Provider.
- Potential for dilution if equity grants are issued frequently.
Future Outlook
The restricted stock is scheduled to vest on the earlier of the one-year anniversary of the grant date or the day prior to the 2027 annual meeting of stockholders, subject to continued service.
Industry Context
StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice to ensure long-term alignment with shareholder value in the technology and software sector.
Comparison to Industry Standards
- The grant of restricted stock to directors is consistent with standard compensation practices for small-cap technology firms.
- Vesting schedules tied to annual meetings are common practice to ensure director retention through the proxy cycle.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Compensation | Grant of restricted stock under the Amended and Restated 2013 Equity Incentive Plan. | 06/11/2026 | Standard alignment of director incentives. |
Stakeholder Impact
- Shareholders: Minor dilution impact; alignment of director incentives with company performance.
Next Steps
- Vesting of the 7,500 restricted shares on the earlier of June 11, 2027, or the day prior to the 2027 annual meeting.
Key Dates
| Date | Description |
|---|---|
| 06/11/2026 | Date of the restricted stock grant transaction. |
| 06/15/2026 | Date the Form 4 was filed with the SEC. |
Keywords
VirnetX, VHC, Form 4, Insider Trading, Equity Grant, Director Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.